Genetic etiologies of the electrical status epilepticus during slow wave sleep: systematic review
Autor: | Miriam Kessi, Nan Pang, Juan Xiong, Haolin Duan, Fei Yin, Jing Peng, Lifen Yang |
---|---|
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Pediatrics medicine.medical_specialty lcsh:QH426-470 DNA Copy Number Variations MEDLINE Review Status epilepticus Biology Sleep Slow-Wave Monogenic mutations 03 medical and health sciences Epilepsy Status Epilepticus 0302 clinical medicine Channelopathy Neuroserpin Gene duplication Genetics medicine Humans Continuous spike-wave of slow sleep Copy number variations Copy-number variation Genetics (clinical) Electroencephalography medicine.disease lcsh:Genetics Electrical status epilepticus during slow-wave sleep 030104 developmental biology Mutation Etiology Channelopathies medicine.symptom Epilepsy aphasia spectrum 030217 neurology & neurosurgery Research Article |
Zdroj: | BMC Genetics BMC Genetics, Vol 19, Iss 1, Pp 1-15 (2018) |
ISSN: | 1471-2156 |
Popis: | Background Electrical status epilepticus during slow-wave sleep (ESESS) which is also known as continuous spike-wave of slow sleep (CSWSS) is type of electroencephalographic (EEG) pattern which is seen in ESESS/CSWSS/epilepsy aphasia spectrum. This EEG pattern can occur alone or with other syndromes. Its etiology is not clear, however, brain malformations, immune disorders, and genetic etiologies are suspected to contribute. We aimed to perform a systematic review of all genetic etiologies which have been reported to associate with ESESS/CSWSS/epilepsy-aphasia spectrum. We further aimed to identify the common underlying pathway which can explain it. To our knowledge, there is no available systematic review of genetic etiologies of ESESS/CSWSS/epilepsy-aphasia spectrum. MEDLINE, EMBASE, PubMed and Cochrane review database were searched, using terms specific to electrical status epilepticus during sleep or continuous spike–wave discharges during slow sleep or epilepsy-aphasia spectrum and of studies of genetic etiologies. These included monogenic mutations and copy number variations (CNVs). For each suspected dosage-sensitive gene, further studies were performed through OMIM and PubMed database. Results Twenty-six studies out of the 136 identified studies satisfied our inclusion criteria. I51 cases were identified among those 26 studies. 16 studies reported 11 monogenic mutations: SCN2A (N = 6), NHE6/SLC9A6 (N = 1), DRPLA/ ATN1 (N = 1), Neuroserpin/SRPX2 (N = 1), OPA3 (N = 1), KCNQ2 (N = 2), KCNA2 (N = 5), GRIN2A (N = 34), CNKSR2 (N = 2), SLC6A1 (N = 2) and KCNB1 (N = 5). 10 studies reported 89 CNVs including 9 recurrent ones: Xp22.12 deletion encompassing CNKSR2 (N = 6), 16p13 deletion encompassing GRIN2A (N = 4), 15q11.2–13.1 duplication (N = 15), 3q29 duplication (N = 11), 11p13 duplication (N = 2), 10q21.3 deletion (N = 2), 3q25 deletion (N = 2), 8p23.3 deletion (N = 2) and 9p24.2 (N = 2). 68 of the reported genetic etiologies including monogenic mutations and CNVs were detected in patients with ESESS/CSWSS/epilepsy aphasia spectrum solely. The most common underlying pathway was channelopathy (N = 56). Conclusions Our review suggests that genetic etiologies have a role to play in the occurrence of ESESS/CSWSS/epilepsy-aphasia spectrum. The common underlying pathway is channelopathy. Therefore we propose more genetic studies to be done for more discoveries which can pave a way for proper drug identification. We also suggest development of common cut-off value for spike-wave index to ensure common language among clinicians and researchers. Electronic supplementary material The online version of this article (10.1186/s12863-018-0628-5) contains supplementary material, which is available to authorized users. |
Databáze: | OpenAIRE |
Externí odkaz: |